![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/20/2901563/0/en/Sunstone-Therapies-to-participate-in-the-H-C-Wainwright-5th-Annual-Neuro-Perspectives-Conference.html
https://www.globenewswire.com//news-release/2023/12/18/2797687/0/en/Sunstone-Therapies-Announces-Publication-of-Positive-Phase-2-Study-Results-in-Cancer.html
https://www.globenewswire.com//news-release/2023/12/14/2796143/0/en/Sunstone-Therapies-Celebrates-Three-Year-Anniversary-With-More-Than-100-Psychedelic-Assisted-Therapy-Treatments-Completed.html
https://www.globenewswire.com//news-release/2023/11/06/2773942/0/en/Sunstone-Therapies-Announces-Start-of-First-Study-of-Multiple-Doses-of-Psilocybin-in-Treatment-of-Depression-in-Patients-with-Cancer.html
https://www.globenewswire.com//news-release/2023/10/03/2753440/0/en/Sunstone-Therapies-Announces-Expansion-of-Innovative-Dyad-Study.html